Absence of S100A12 in mouse: implications for RAGE-S100A12 interaction.

نویسندگان

  • Georg Fuellen
  • Dirk Foell
  • Wolfgang Nacken
  • Clemens Sorg
  • Claus Kerkhoff
چکیده

protein that binds to a repeated EP motif in the intracellular region of LAG-3, may participate in the down-regulation of the CD3/TCR activation pathway. Eur. J. Immunol. 31, 2885–2891 14 Huard, B. et al. (1995) CD4/major histocompatibility complex class II interaction analyzed with CD4and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins. Eur. J. Immunol. 25, 2718–2721 15 Barten, R. et al. (2001) Divergent and convergent evolution of NK-cell receptors. Trends Immunol. 22, 52–57 16 Huard, B. et al. (1998) LAG-3 does not define a specific mode of natural killing in human. Immunol. Lett. 61, 109–112 17 Hung, L.Y. et al. (2000) Protein 4.1 R-135 interacts with a novel centrosomal protein (CPAP) which is associated with the g-tubulin complex. Mol. Cell. Biol. 20, 7813–7825 18 Buisson, S. and Triebel, F. (2003) MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine receptor expression by human dendritic cells. Vaccine 21, 862–868 19 Prigent, P. et al. (1999) LAG-3 induces tumor regression and antitumor immune responses in vivo. Eur. J. Immunol. 29, 3867–3876 20 Cappello, P. et al. (2003) LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. Cancer Res. 63, 2518–2525 21 Setterblad, N. et al. (2003) Composition of MHC class II-enriched lipid microdomains is modified during maturation of primary dendritic cells. J. Leukoc. Biol. 74, 40–48 22 Machy, P. et al. (2002) Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4þ T cells engaging class II molecules in cholesterol-rich domains. J. Immunol. 168, 1172–1180 23 Buatois, N. et al., MHC class II–peptide complexes in dendritic cell lipid microdomains initiate the CD4 Th1 phenotype. J. Immunol. (in press) 24 Lienhardt, C. et al. (2002) Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur. J. Immunol. 32, 1605–1613 25 Phan, G.Q. et al. (2003) Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl. Acad. Sci. U. S. A. 100, 8372–8377

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Decreased Expression Levels of S100A12 and RAGE May Be Associated with Chronic HBV Infection

Background and Aims: Engagement of the receptor for advanced glycation end products (RAGE) and its ligand “S100A12 protein” induce a cascade of reactions that eventually might lead to develop an inflammatory response dependent on NF-κB. Although involvement of S100A12 and RAGE in some autoimmune disease have proved, in chronic hepatitis B (CHB) infection functions of the prote...

متن کامل

Serum S100A12 (EN-RAGE) levels in patients with decreased renal function and subclinical chronic inflammatory disease.

BACKGROUND The calcium-binding protein S100A12 (EN-RAGE) causes inflammation through interaction with the multiligand receptor for advanced glycation end products (RAGE). The aim of the study was to determine S100A12 levels and describe their relationship to inflammatory markers in patients with decreased renal function. METHODS The studied group consisted of 46 patients with various degrees ...

متن کامل

Receptor for advanced glycation end products involved in circulating endothelial cells release from human coronary endothelial cells induced by C-reactive protein

Objective(s): This study was designed to investigate the effect of receptor for advanced glycation end products (RAGE), S100A12 and C-reactive protein (CRP) on the release of circulating endothelial cells (CECs) from human coronary artery endothelial cells (HCAECs). Materials and Methods: HCAECs were cultured in increasing concentration of CRP (0, 12.5, 25, 50μg/ml) or S100A12 protein (0, 4, 1...

متن کامل

Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast

The receptor for advanced glycation end products (RAGE), a transmembrane receptor in the immunoglobulin superfamily, is involved in several inflammatory processes. RAGE induces cellular signaling pathways upon binding with various ligands, such as advanced glycation end products (AGEs), β-amyloids, and S100 proteins. The solution structure of S100A12 and the V ligand-binding region of RAGE have...

متن کامل

S100A12 and RAGE expression in human bladder transitional cell carcinoma: a role for the ligand/RAGE axis in tumor progression?

BACKGROUND Transitional cell carcinoma (TCC) and prostate cancer are the most frequent cancers in the male genitourinary tract. Measurement of biological biomarkers may facilitate clinical monitoring and aid early diagnosis of TCC. The aim of the present investigation was to detect the mRNA levels of S100A12 and RAGE (receptor for advanced glycation end products) in patients suffering from blad...

متن کامل

Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis.

OBJECTIVES Infiltration of synovial tissue by neutrophils is crucial in rheumatoid arthritis (RA), psoriatic arthritis (PsA) and seronegative arthritis (SA). Altered vascular function and endothelial activation are important in PsA. S100A12 (EN-RAGE) is secreted by activated granulocytes and binds to the receptor for advanced glycation end products, which induces nuclear factor (NF)-kappaB-depe...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Trends in immunology

دوره 24 12  شماره 

صفحات  -

تاریخ انتشار 2003